Similarly, another multicenter study found that a combined model composed of clinical data (AFP, albumin-bilirubin grade, tumor margin, and liver cirrhosis) and three-feature radiomic signatures achieved high prognostic performance in predicting recurrence in post-resection patients [132]. This evidence concerns the gene AFP and neoplasm.